FDC logo

FDC share news, announcements and annual reports

NSE: FDCBSE: 531599Pharmaceuticals & BiotechnologySmall Cap

FDC Limited · Face value ₹1 · Listed Apr 1996 on BSE, Aug 1997 on NSE
Last close ₹377.00down ₹0.15 (0.04%)BSE ₹376.65

Share price at the NSE close on 30 Oct 2026. Previous close ₹377.15.

30 Oct: open ₹378.50, high ₹383.40, low ₹376.10

52-week range of traded prices to 30 Oct 2026
₹312.95Low, 30 Mar 2026₹473.60High, 3 Nov 2025
Market cap
₹6,138 Cr719th largest listed
P/E
19.59
P/B
2.30
Dividend yield
1.33%
ROE
12.3%
ROCE
11.5%
Debt to equity
0.00
Volume, NSE
2,46,86268.2% delivered

FDC board meetings

124 filed, newest first. Page 2 of 3.

  1. Mar 2020

  2. Feb 2020

  3. Jan 2020

  4. Nov 2019

  5. Oct 2019

  6. Aug 2019

  7. Jul 2019

  8. May 2019

  9. Feb 2019

  10. Jan 2019

  11. Oct 2018

  12. Jul 2018

  13. May 2018

  14. Feb 2018

  15. Jan 2018

  16. Oct 2017

  17. Jul 2017

  18. May 2017

  19. Feb 2017

  20. Jan 2017

  21. Oct 2016

  22. Jul 2016

  23. May 2016

  24. Mar 2016

  25. Jan 2016

  26. Oct 2015

  27. Sep 2015

  28. Jul 2015

  29. May 2015

  30. Apr 2015

  31. Jan 2015

    • 9 Jan · Board meeting

      To inter-alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2014.
  32. Oct 2014

    • 14 Oct · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter and six months ended September 30, 2014.
  33. Sep 2014

  34. Aug 2014

  35. Jun 2014

    • 26 Jun · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2014.
  36. May 2014

    • 5 May · Board meeting

      To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2014. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2014.
  37. Dec 2013

    • 30 Dec · Board meeting

      To inter alia consider and approve the unaudited financial results of the Company for the quarter and nine months ending December 31, 2013.
  38. Sep 2013

    • 16 Sep · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2013.
  39. Jul 2013

    • 16 Jul · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2013.
  40. Apr 2013

    • 17 Apr · Board meeting

      To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2013. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2013.
  41. Jan 2013

    • 8 Jan · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2012.
  42. Oct 2012

    • 15 Oct · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2012
  43. Jul 2012

    • 11 Jul · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended June 30, 2012.
  44. May 2012

    • 8 May · Board meeting

      To interalia, consider and approve the Audited Financial Results of the Company for the year ended March 31, 2012. The board will also interalia consider the recommendation of dividend, if any, for the year ended March 31, 2012.
  45. Jan 2012

    • 24 Jan · Board meeting

      Meeting of the Buyback Committee to discuss the closure of the ongoing buyback of equity shares of face value of Re. 1/- each will be held on January 25, 2012.
    • 19 Jan · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2011.
  46. Oct 2011

    • 14 Oct · Board meeting

      To inter alia, consider and approve the unaudited financial results of the Company for the quarter ended September 30, 2011.